drugset / Trial / NCT05901337

Cupping Therapy on Immune System in Post Covid -19

NCT05901337

Completed 76 enrolled Cairo University
RandomizedParallel-groupSingle-blindTreatment

Summary

Purpose of this study is to investigate 1. The effect of Dry cupping therapy on T-Lymphocyte in post covid-19 patients. 2. The effect of Dry cupping therapy on serum Cytokine in post covid-19 patients. 3. The effect of Dry cupping therapy on Immunoglobulin IgA. 4. The effect of Dry cupping therapy on Immunoglobulin IgM. 5. The effect of Dry cupping therapy on Immunoglobulin IgG. seventy six patients of both genders with deficiency in T-Lymphocyte number,,higher level of serum cytokine and lower immunoglobulin IgA,IgM,IgG after two weeks of recovery from covid-19 . Age range from Twenty one to Sixty six years old .They participated in the study and recruited from surveillance unit of Shobra general hospital .These patients recruited by phone and have been offered to participate in the programme.The patients were divided equally into two groups (A and B). Assessment was done before and after treatment. T-Lymphocyte, serum cytokine and immunoglobulin IgA, IgM and IgG were analyzed by kenza 240 TX from fluorescence-labeled flow cytometry. Disposable cupping therapy instrument was used in treatment of group (A) in addition to traditional medical treatment in the form of vitamin C, D and anticoagulant drugs. Traditional medical treatment only was used in treatment of group (B).The obtained results of this study will determine the significant improvement of participated two groups. .

Timeline

Start
2022-03-07
Primary completion
2022-06-21
Completion
2023-06-01

Drugs

EvaluationDrugModalityDoseRoute
Background Enoxaparin sodium Other / unclassified 30 mg Subcutaneous
Background Vitamin D Other / unclassified 600 iu
Background Vitamine C Unknown 200 mg

Indications

No indication recorded.